Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Partridge, Ann"'
Autor:
Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gelber SI; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zheng Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ruddy KJ; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Tamimi RM; Department of Population Health Sciences, Weill Cornell Medicine, New York, New York., Peppercorn J; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Schapira L; Stanford University, Palo Alto, California., Borges VF; Department of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado., Come SE; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Lambertini M; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; Medical Oncology Clinic, IRCCS San Maritino Polyclinic Hospital, Genoa, Italy., Rosenberg SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2021 Apr 01; Vol. 127 (7), pp. 1021-1028. Date of Electronic Publication: 2020 Dec 01.
Autor:
Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Barry WT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts., Greaney ML; Department of Kinesiology, University of Rhode Island at Kingston, Kingston, Rhode Island., Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts., Sprunck-Harrild KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rosenberg SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts., Baker EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hoverman JR; Texas Oncology PA, Austin, Texas., Emmons KM; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2019 Jun 01; Vol. 125 (11), pp. 1799-1806. Date of Electronic Publication: 2019 Feb 01.
Autor:
Korde LA; 1 Division of Medical Oncology, University of Washington , Seattle, Washington., Partridge AH; 2 Dana-Farber Cancer Institute , Boston, Massachusetts., Esser M; 3 Young Survival Coalition , New York, New York., Lewis S; 3 Young Survival Coalition , New York, New York., Simha J; 3 Young Survival Coalition , New York, New York., Johnson RH; 4 Mary Bridge Children's Hospital , Multicare Health System, Tacoma, Washington.
Publikováno v:
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2015 Mar; Vol. 4 (1), pp. 34-43.
Autor:
Ruddy KJ; Dana-Farber Cancer Institute, Boston, MA 02215, USA., Partridge AH
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2012 Oct 20; Vol. 30 (30), pp. 3705-11. Date of Electronic Publication: 2012 Sep 24.
Autor:
Partridge AH
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2012 Feb 10; Vol. 30 (5), pp. 479-81. Date of Electronic Publication: 2012 Jan 09.
Autor:
Pagani O; Institute of Oncology of Southern Switzerland (IOSI) and International Breast Cancer Study Group (IBCSG), Ospedale Italiano, 6902, Viganello, Switzerland. Olivia.pagani@ibcsg.org, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2011 Sep; Vol. 129 (2), pp. 309-17. Date of Electronic Publication: 2011 Jun 23.
Autor:
Partridge AH; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA 02115, USA. ahpartridge@partners.org, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, Przypyszny M, Winer EP
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2008 Feb; Vol. 8 (1), pp. 65-9.
Autor:
Lee SJ; Dana-Farber Cancer Institute, Boston, MA, USA., Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Jun 20; Vol. 24 (18), pp. 2917-31. Date of Electronic Publication: 2006 May 01.
Autor:
Partridge AH, Winer EP
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Jul 01; Vol. 23 (19), pp. 4259-61. Date of Electronic Publication: 2005 Apr 11.
Autor:
Partridge AH; Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. ahpartridge@partners.org, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Oct 15; Vol. 22 (20), pp. 4174-83.